SNPX — Synaptogenix Cashflow Statement
0.000.00%
Last trade - 00:00- $3.36m
- -$14.29m
- 29
- 50
- 13
- 21
Annual cashflow statement for Synaptogenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -12.7 | -12.6 | -5.57 | -6.04 | -12.8 |
| Depreciation | |||||
| Non-Cash Items | 3.9 | 3.87 | -5.03 | 0.501 | 7.38 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.694 | 0.026 | -0.615 | 0.358 | 0.502 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.1 | -8.71 | -11.2 | -5.17 | -4.88 |
| Capital Expenditures | -0.005 | -0.003 | -0.007 | -0.003 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -2 | -1 |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.005 | -0.003 | -0.007 | -2 | -1 |
| Financing Cash Flow Items | -20 | -0.002 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -3.48 | 37.1 | 14.5 | -1.64 | -5.12 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11.6 | 28.4 | 3.26 | -8.82 | -11 |